BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 8 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 8 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 9 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 10 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 10 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 11 hours ago Atmus Welcomes Heath Sharp to Board of Directors 13 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 13 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 3 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 8 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 8 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 9 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 10 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 10 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 11 hours ago Atmus Welcomes Heath Sharp to Board of Directors 13 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 13 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 3 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago
ADVERTISEMENT
Market News

MannKind Corporation (MNKD): Q4 2019 Earnings Snapshot

— MannKind Corporation (NASDAQ: MNKD) reported Q4 2019 loss of $0.07 per share, vs. a loss of $0.07 expected. — Total revenue amounted to $16 million, vs. $15 million expected. — Afrezza net revenue grew 35% to $7.8 million. — Collaborations and services revenue fell 20% to $8.2 million. — Research and development expenses increased […]

$MNKD February 25, 2020 1 min read
Earnings Update by AlphaStreet

— MannKind Corporation (NASDAQ: MNKD) reported Q4 2019 loss of $0.07 per share, vs. a loss of $0.07 expected.

— Total revenue amounted to $16 million, vs. $15 million
expected.

— Afrezza net revenue grew 35% to $7.8 million.

— Collaborations and services revenue fell 20% to $8.2
million.

— Research and development expenses increased 82% to $2 million.

ADVERTISEMENT

— Cash, cash equivalents, restricted cash and short-term
investments at December 31, 2019 was $50.2 million.

— MNKD shares gained 3.9% immediately following the
announcement.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

ADVERTISEMENT